Du L - Search Results

1

8-Cl-Ado and 8-NH₂-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia.

Guo J, Buettner R, Du L, Li Z, Liu W, Su R, Chen Z, Che Y, Zhang Y, Ma R, Nguyen LXT, Moore RE, Khyatiben P, Chen MH, Patrick P, Wu X, Marcucci G, Wang L, Horne D, Chen J, Yang Y, Rosen ST. Guo J, et al. Among authors: du l. Leukemia. 2024 Apr 20. doi: 10.1038/s41375-024-02222-w. Online ahead of print. Leukemia. 2024. PMID: 38643304

2

Targeting SUMOylation in cancer.

Du L, Liu W, Rosen ST. Du L, et al. Curr Opin Oncol. 2021 Sep 1;33(5):520-525. doi: 10.1097/CCO.0000000000000765. Curr Opin Oncol. 2021. PMID: 34280172 Review.

3

SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide.

Du L, Liu W, Pichiorri F, Rosen ST. Du L, et al. Cancer Gene Ther. 2023 Apr;30(4):567-574. doi: 10.1038/s41417-022-00450-9. Epub 2022 Mar 25. Cancer Gene Ther. 2023. PMID: 35338347 Free PMC article.

4

Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression.

Du L, Liu W, Rosen ST, Chen Y. Du L, et al. J Mol Biol. 2023 Mar 1;435(5):167968. doi: 10.1016/j.jmb.2023.167968. Epub 2023 Jan 18. J Mol Biol. 2023. PMID: 36681180

5

SUMOylation of E2F1 Regulates Expression of EZH2.

Du L, Fakih MG, Rosen ST, Chen Y. Du L, et al. Cancer Res. 2020 Oct 1;80(19):4212-4223. doi: 10.1158/0008-5472.CAN-20-1259. Epub 2020 Aug 14. Cancer Res. 2020. PMID: 32816857 Free PMC article.

6

SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma.

Du L, Liu W, Aldana-Masangkay G, Pozhitkov A, Pichiorri F, Chen Y, Rosen ST. Du L, et al. J Exp Clin Cancer Res. 2022 Jan 4;41(1):8. doi: 10.1186/s13046-021-02226-9. J Exp Clin Cancer Res. 2022. PMID: 34983615 Free PMC article.

7

Regulation of miR-34b/c-targeted gene expression program by SUMOylation.

Li YJ, Du L, Aldana-Masangkay G, Wang X, Urak R, Forman SJ, Rosen ST, Chen Y. Li YJ, et al. Among authors: du l. Nucleic Acids Res. 2018 Aug 21;46(14):7108-7123. doi: 10.1093/nar/gky484. Nucleic Acids Res. 2018. PMID: 29893976 Free PMC article.

8

Regulation of Enhancers by SUMOylation Through TFAP2C Binding and Recruitment of HDAC Complex to the Chromatin.

Abeywardana T, Wu X, Huang ST, Aldana Masangkay G, Rodin AS, Branciamore S, Gogoshin G, Li A, Du L, Tharuka N, Tomaino R, Chen Y. Abeywardana T, et al. Among authors: du l. Res Sq [Preprint]. 2024 Apr 2:rs.3.rs-4201913. doi: 10.21203/rs.3.rs-4201913/v1. Res Sq. 2024. PMID: 38645262 Free PMC article. Preprint.

9

Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.

Li YJ, Du L, Wang J, Vega R, Lee TD, Miao Y, Aldana-Masangkay G, Samuels ER, Li B, Ouyang SX, Colayco SA, Bobkova EV, Divlianska DB, Sergienko E, Chung TDY, Fakih M, Chen Y. Li YJ, et al. Among authors: du l. Cell Chem Biol. 2019 Feb 21;26(2):278-288.e6. doi: 10.1016/j.chembiol.2018.10.026. Epub 2018 Dec 20. Cell Chem Biol. 2019. PMID: 30581133 Free PMC article.

10

Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal.

Du L, Li YJ, Fakih M, Wiatrek RL, Duldulao M, Chen Z, Chu P, Garcia-Aguilar J, Chen Y. Du L, et al. Nat Commun. 2016 Jul 28;7:12326. doi: 10.1038/ncomms12326. Nat Commun. 2016. PMID: 27465491 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,588 results

Search Page